APA (7th ed.) Citation

MA, D., R, A., Y, M., FSR, R., A, P., M, H., . . . K, A. (2024). Combination of spironolactone and sitagliptin improves clinical outcomes of outpatients with COVID-19: A prospective cohort study. Journal of endocrinological investigation, 47(1), 235. https://doi.org/10.1007/s40618-023-02141-0

Chicago Style (17th ed.) Citation

MA, Davarpanah, Adatorwovor R, Mansoori Y, Ramsheh FSR, Parsa A, Hajiani M, Faramarzi H, Kavuluru R, and Asadipooya K. "Combination of Spironolactone and Sitagliptin Improves Clinical Outcomes of Outpatients with COVID-19: A Prospective Cohort Study." Journal of Endocrinological Investigation 47, no. 1 (2024): 235. https://doi.org/10.1007/s40618-023-02141-0.

MLA (9th ed.) Citation

MA, Davarpanah, et al. "Combination of Spironolactone and Sitagliptin Improves Clinical Outcomes of Outpatients with COVID-19: A Prospective Cohort Study." Journal of Endocrinological Investigation, vol. 47, no. 1, 2024, p. 235, https://doi.org/10.1007/s40618-023-02141-0.